JOHN W KOZARICH
CIK 1223000 · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$14.10M
Companies
5
Total Filings
104
Lifetime Open-Market Net
-$6.46M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LGND | Director | 42,622 | $293.15 | $12.49M | -$6.63M | 73 | 2026-06-09 |
| Intec Pharma Ltd. (NTEC) Delisted | Director | 151,761 | $9.63 | $1.46M | $45.9K | 2 | 2020-07-17 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Director | 29,000 | — | — | $0 | 5 | 2019-05-10 |
| QLTI | Director | 57,000 | $28.14 | $1.60M | $115.6K | 9 | 2016-06-21 |
| Corium International, Inc. (CORI) Delisted | Director | — | — | — | $0 | 1 | 2014-12-05 |
Recent Filings · Page 4 of 11
104 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-05-16 | LGND | Notice (144) | −4,444 | -$343.1K | EDGAR |
| 2023-05-10 | LGND | Mixed | — | -$370.0K | EDGAR |
| 2023-05-08 | LGND | Notice (144) | −6,408 | -$487.0K | EDGAR |
| 2022-12-27 | LGND | Grant (A) | — | $0 | EDGAR |
| 2022-06-13 | LGND | Grant (A) | +1,004 | $0 | EDGAR |
| 2022-03-01 | LGND | Mixed | +6,427 | -$1.3K | EDGAR |
| 2021-06-07 | LGND | Grant (A) | +630 | $0 | EDGAR |
| 2021-05-13 | LGND | Mixed | +4,444 | -$1.3K | EDGAR |
| 2021-02-23 | LGND | Exer (M) | +2,500 | $25.3K | EDGAR |
| 2020-07-17 | Intec Pharma Ltd. (NTEC) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.